Biphasic Scatchard plots of oestrogen receptors are associated with low pS2 levels in human breast cancers

被引:3
|
作者
Marsigliante, S
Biscozzo, L
Leo, G
Storelli, C
机构
[1] Univ Lecce, Dipartimento Biol, Lab Fisiol, I-73100 Lecce, Italy
[2] Osped V Fazzi, Mol Biol Lab, I-73100 Lecce, Italy
关键词
breast cancer; Scatchard analysis; ER; pS2;
D O I
10.1016/S0304-3835(99)00178-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a series of 100 breast rumours, oestrogen receptors (ER) were analysed by Scatchard plots, progesterone receptors (PR) by enzyme immunoassay and pS2 by an immunoradiometric assay. Scatchard analysis gave information on receptor heterogeneity in that there was a large variation in K-d values obtained, from 0.001-2.95 nM. This variation was largely confined to tumours containing less than 70 fmol receptor per mg protein, while tumours with higher receptor concentrations were a more homogeneous population with low K-d values. An obvious correlation between ER and PR was found; moreover, pS2 was correlated to both ER and PR. In addition, 20 of the 100 tumours gave biphasic Scatchard plots, indicating the presence of at least two oestrogen-binding moieties, with K-d values and concentrations both in the range of those of receptors, The tumours displaying biphasic Scatchard plots had very low pS2 expression, regardless of ER concentrations; this was not true for PR. It is suggested that variability in responses to endocrine therapy may be related to the heterogeneity of the ER present in breast tumours, (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [21] Expression of a breast-cancer-associated protein (pS2) in human neuro-endocrine tumours
    Wang, DG
    Johnston, CF
    Liu, WH
    Sloan, JM
    Buchanan, KD
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (03) : 270 - 274
  • [22] Immunoradiometric measurement of pS2 in breast cancer: Correlation with steroid receptors and plasminogen activators
    Luqmani, Yunus
    Temmim, Labiba
    Memon, Anjum
    Parkar, Abdulhamid
    Ali, Madja
    Motawy, Mohammed
    Baker, Hisham
    Acta Oncologica, 38 (06): : 805 - 814
  • [23] Immunoradiometric measurement of pS2 in breast cancer -: Correlation with steroid receptors and plasminogen activators
    Luqmani, Y
    Temmim, L
    Memon, A
    Parkar, A
    Ali, M
    Motawy, M
    Baker, H
    ACTA ONCOLOGICA, 1999, 38 (06) : 805 - 814
  • [24] EXPRESSION OF C-ERBB2, TGF-BETA-1-GENE AND PS2 GENE IN PRIMARY HUMAN BREAST CANCERS
    DELVENNE, CG
    WINKLERGOL, RA
    PICCART, MJ
    HUSTIN, J
    MICHAUX, D
    LECLERCQ, G
    NOGARET, JM
    AUTIER, P
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 700 - 705
  • [25] Urinary pS2/TFF1 levels in the management of hormonodependent breast carcinomas
    Chenard, MP
    Tomasetto, C
    Bellocq, JP
    Rio, MC
    PEPTIDES, 2004, 25 (05) : 737 - 743
  • [26] IMMUNOHISTOCHEMISTRY OF PS2 IN NORMAL HUMAN BREAST AND IN VARIOUS HISTOLOGICAL FORMS OF BREAST-TUMORS
    PALLUD, C
    LEDOUSSAL, V
    PICHON, MF
    PRUDHOMME, JF
    HACENE, K
    MILGROM, E
    HISTOPATHOLOGY, 1993, 23 (03) : 249 - 256
  • [27] BINDING CHARACTERISTICS OF I-125 IODOCYANOPINDOLOL TO BETA-ADRENERGIC RECEPTORS - BIPHASIC SCATCHARD PLOTS .2. EFFECTS OF SELECTIVE ANTAGONISTS
    TSUCHIHASHI, H
    NAGATOMO, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1987, 35 (08) : 3425 - 3432
  • [28] pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
    Gillesby, BE
    Zacharewski, TR
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (03) : 253 - 265
  • [29] pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
    Bradley E. Gillesby
    Timothy R. Zacharewski
    Breast Cancer Research and Treatment, 1999, 56 (3) : 251 - 263
  • [30] pS2 expression in infiltrating ductal carcinoma of the breast correlates with oestrogen receptor positivity but not with histological grade and lymph node status
    Looi, LM
    Azura, WW
    Cheah, PL
    Ng, MH
    PATHOLOGY, 2001, 33 (03) : 283 - 286